Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Substance in cancer medicine could prevent heart attacks

23.11.2011
A substance in medicines for cancer and epilepsy could also prevent heart attacks, according to researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden,, who have been using it to stimulate the body’s own defence system against blood clots.

Heart attacks are normally caused by the formation of a blood clot in one of the blood vessels that supply the heart with oxygen and nutrients. The clot reduces the supply of oxygen, which can very quickly result in irreparable damage to the heart.

The body´s own protection

The body has a natural defence system to prevent blood clots – the fibrinolytic system – which ““sprays““ a special enzyme over the clots to break them down before they manage to obstruct the vessel. However, in order to function properly, this system needs sufficient quantities of the enzyme to be stored in the vessel wall. Unfortunately these stores are often depleted because of hereditary and lifestyle factors, such as high blood pressure, smoking and overweight, which probably increases the risk of a heart attack.

New ways of preventing heart attack

Researchers at the University of Gothenburg’s Sahlgrenska Academy have been looking at a way to stimulate the clot-dissolving system. The results are promising and open the door to new ways of preventing heart attacks.

“We’re trying to find a medicine that boosts the stores of the enzyme as this probably would help the body to prevent heart attacks,” says Pia Larsson at the Sahlgrenska Academy, who is basing her thesis on the study.

Stimulates enzyme production

Previously tested substances have proved unsuitable, mainly because of their unwanted side-effects. In the present study the Sahlgrenska researchers used HDAC inhibitors, substances new to this particular context, and managed to stimulate production of the relevant enzyme.

“We found that treatment with HDAC inhibitors dramatically increased production of the clot-dissolving enzyme, and that this occurred at far lower concentrations than expected,” says Larsson.

Side-effects well known

The advantage of HDAC inhibitors is that they are already used in medication for illnesses such as epilepsy and cancer, which means that their pharmacological properties and side-effects are known.

Larsson says that more research is needed before a drug to prevent heart attacks can be launched.

“Our trials have been carried out on cultured cells from the vessel wall and we can’t guarantee that the cells, when present in the body, will behave in exactly the same way. The results must therefore be tested on people before we can draw any firm conclusions.”

Furhter investigation

The Sahlgrenska researchers are therefore preparing the first in a series of studies on human subjects to further investigate the effect of HDAC inhibitors on the clot-dissolving enzyme.

The thesis, “Regulation of Vascular Endothelial t-PA Expression in Inflammation – Potential Target for Pharmacological Modulation” was defended on 18 November.

For more information, please contact: Pia Larsson
Telephone: +46 (0)736 240 394
E-mail: pia.larsson@gu.se

Helena Aaberg | idw
Further information:
http://www.gu.se

More articles from Life Sciences:

nachricht Molecular microscopy illuminates molecular motor motion
26.07.2017 | Penn State

nachricht New virus discovered in migratory bird in Rio Grande do Sul, Brazil
26.07.2017 | Fundação de Amparo à Pesquisa do Estado de São Paulo

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Carbon Nanotubes Turn Electrical Current into Light-emitting Quasi-particles

Strong light-matter coupling in these semiconducting tubes may hold the key to electrically pumped lasers

Light-matter quasi-particles can be generated electrically in semiconducting carbon nanotubes. Material scientists and physicists from Heidelberg University...

Im Focus: Flexible proximity sensor creates smart surfaces

Fraunhofer IPA has developed a proximity sensor made from silicone and carbon nanotubes (CNT) which detects objects and determines their position. The materials and printing process used mean that the sensor is extremely flexible, economical and can be used for large surfaces. Industry and research partners can use and further develop this innovation straight away.

At first glance, the proximity sensor appears to be nothing special: a thin, elastic layer of silicone onto which black square surfaces are printed, but these...

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

 
Latest News

CCNY physicists master unexplored electron property

26.07.2017 | Physics and Astronomy

Molecular microscopy illuminates molecular motor motion

26.07.2017 | Life Sciences

Large-Mouthed Fish Was Top Predator After Mass Extinction

26.07.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>